News - Futures > Community: Commentaries

Recent Commentaries tagged (gsk)

Showing Posts 1 - 2 out of 2 found.
Feb 8 2012

Amgen Upped to Outperform - Analyst Blog

by ZacksResearch 0 comment(s).
Overall Rating: Average rating is: 0 stars.
ZacksResearch

Following the release of fourth quarter and full year 2011 results, we upgraded biotech major, Amgen (AMGN), to Outperform. Although the company missed estimates in the fourth quarter of 2011, guidance for 2012 was better-than-expected. The company expects earnings in the range of $5.90 - $6.15 ...


Read More » Tags: analyst-blog | amgn | gsk | miti | wpi


Feb 3 2012

Incivek Catalyst at Play for Vertex -...

by ZacksResearch 0 comment(s).
Overall Rating: Average rating is: 0 stars.
ZacksResearch

Vertex Pharmaceuticals Inc. (VRTX) posted fourth quarter 2011 earnings (including stock-based compensation expense) of 72 cents per share, missing the Zacks Consensus Estimate of 75 cents. However, fourth quarter earnings represented a huge turn around from the year-ago loss of 85 cents. The 2011...


Read More » Tags: analyst-blog | gsk | jnj | vrtx | stocks